Well as a start you can look at the pipelines on websites of Pharma companies with checkpoint inhibitor- BMS, Merck, Roche, Astra, you’ll see numerous trials going on with various combinations with other new and existing drug classes. If you searched clinical trials .gov you’d also find 100s. This is huge field.
there are already approved combinations eg Nivolumab plus ipilimumab.
Nox is just one of very many large Pharma and small biotechs playing in this combination immunotherapy field (and iconic trial isn’t technically Nox’s anyway, it’s investigator initiated I read).
Well as a start you can look at the pipelines on websites of...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $11.03K | 105.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 418372 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 102513 | 3 |
View Market Depth
| Last trade - 15.45pm 27/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |